To assess whether NK cells were involved in antitumor response generated by fasting, Delconte and her team depleted these ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...

Integrative cancer care merges conventional treatments like chemotherapy and surgery with research-based traditional medicine ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Plus Therapeutics (PSTV) has closed a private placement with aggregate initial upfront proceeds of approximately $3.7 million and received a ...

Million Private Placement Financing from Existing Investors $2.0 Million Funding Advance from the Cancer Prevention and ...

A combination immunotherapy may help cure a majority of patients with melanoma -- a deadly skin cancer -- that has spread to ...